Valuation: Hugel, Inc.

Market Cap 2,506B 1.86B 1.61B 1.52B 1.38B 2.58B 178B 2.6B 18.15B 6.99B 90.48B 6.99B 6.83B 288B P/E 2026 *
16.4x
P/E 2027 * 12.9x
Enterprise Value 1.95B 1.45M 1.25M 1.18M 1.07M 2.01M 138M 2.03M 14.12M 5.43M 70.37M 5.44M 5.31M 224M EV / Sales 2026 *
3.69x
EV / Sales 2027 * 2.81x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day+0.43%
1 week-4.92%
Current month-7.94%
1 month-11.62%
3 months-5.11%
6 months-3.13%
Current year+0.65%
1 week 225,500
Extreme 225500
244,500
1 month 225,500
Extreme 225500
262,000
Current year 216,500
Extreme 216500
308,500
1 year 208,500
Extreme 208500
327,500
3 years 119,000
Extreme 119000
392,000
5 years 99,700
Extreme 99700
392,000
10 years 75,865.91
Extreme 75865.908
392,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 2022-04-28
Director/Board Member 56 2022-04-28
Director/Board Member 51 2022-04-28
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/25 Exercice 1,200 0.0095%
5/20/25 Sell 1,200 0.0095%
5/19/25 Exercice

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%-4.92%-27.61%+87.10% 1.86B
+1.57%-4.11%+41.74%-3.93% 78.04B
+1.89%+0.78%+523.95%+35.09% 57.48B
+2.68%-1.68%-17.44%-36.27% 57.4B
+0.35%-1.87%-11.03%+27.74% 48.81B
+2.38%-0.05%+1.49%+157.52% 45.5B
+0.10%-1.57%+50.05%-15.06% 32.08B
+0.59%-3.60%+47.04%+93.65% 24.62B
+3.53%-5.42%-1.02%+170.53% 20.77B
+2.24%-1.45%+66.12%+103.91% 15.75B
Average +1.36%-3.53%+67.33%+62.03% 38.23B
Weighted average by Cap. +1.34%-3.44%+93.21%+40.05%

Financials

2026 *2027 *
Net sales 528B 392M 339M 320M 290M 544M 37.45B 548M 3.82B 1.47B 19.05B 1.47B 1.44B 60.6B 641B 476M 412M 389M 353M 661M 45.49B 666M 4.64B 1.79B 23.14B 1.79B 1.75B 73.6B
Net income 171B 127M 110M 104M 94.25M 177M 12.16B 178M 1.24B 478M 6.19B 478M 467M 19.68B 221B 164M 142M 134M 121M 227M 15.65B 229M 1.6B 615M 7.96B 615M 601M 25.33B
Net Debt -557B -413M -358M -338M -306M -574M -39.53B -579M -4.03B -1.55B -20.11B -1.55B -1.52B -63.96B -705B -523M -453M -428M -388M -727M -50.03B -733M -5.11B -1.97B -25.45B -1.97B -1.92B -80.96B
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
620
Date Price Change Volume
26-09-14 ₩232,000.00 +0.43% 31,158
26-09-11 ₩231,000.00 -2.12% 32,932
26-09-10 ₩236,000.00 0.00% 41,740
26-09-09 ₩236,000.00 -0.84% 24,658
26-09-08 ₩238,000.00 -2.06% 22,715
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
232,000.00KRW
Average target price
369,312.50KRW
Spread / Average Target
+59.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A145020 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!